FDA suggests manufacturers add allergy warnings to labels of acetaminophen-containing OTC monograph products due to a risk of rare but serious and potentially fatal skin reactions, including Stevens-Johnson Syndrome.
The recommendation in a draft guidance published Nov
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?